Counterfeit batches of Abhayrab rabies vaccine have been circulating in India since November 2023, prompting international health advisories. While the manufacturer, Indian Immunologicals Limited, asserts the vaccine contents were genuine within tampered packaging, concerns over efficacy remain. This incident highlights critical issues in India's drug supply chain and public health vigilance.
Read the full story on Quick Digest